These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes. Dang Q, Kasibhatla SR, Reddy KR, Jiang T, Reddy MR, Potter SC, Fujitaki JM, van Poelje PD, Huang J, Lipscomb WN, Erion MD. J Am Chem Soc; 2007 Dec 19; 129(50):15491-502. PubMed ID: 18041834 [Abstract] [Full Text] [Related]
13. New hepatic targets for glycaemic control in diabetes. Agius L. Best Pract Res Clin Endocrinol Metab; 2007 Dec 14; 21(4):587-605. PubMed ID: 18054737 [Abstract] [Full Text] [Related]
15. Use of a QM/MM-based FEP method to evaluate the anomalous hydration behavior of simple alkyl amines and amides: application to the design of FBPase inhibitors for the treatment of type-2 diabetes. Reddy MR, Singh UC, Erion MD. J Am Chem Soc; 2011 Jun 01; 133(21):8059-61. PubMed ID: 21545145 [Abstract] [Full Text] [Related]